Panzyga (Immunoglobulin Intravenous (Human), 10%) Correct Coding and Coverage - Revised

December 4, 2019

Panzyga® (Immunoglobulin Intravenous (Human), 10%) is a sterile liquid preparation of highly purified immunoglobulin G (IgG) derived from large pools of human plasma which has recently been approved by the FDA on August 2, 2018. Panzyga® is covered for claims with dates of service on or after August 2, 2018, when the criteria discussed below are met. Read the complete advisory article, Panzyga® (Immunoglobulin Intravenous (Human), 10%) Correct Coding and Coverage - Revised.